Ref.: BL-RE-092816Manufacturer ref.: EH281RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human ITGA2 quantitates human ITGA2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ITGA2.
Accession number
sous-unité alpha 2 du récepteur VLA-2 ; BDPLT9 ; BR ; membre de la famille similaire à l’antigène CD49 B ; CD49B ; récepteur de collagène ; D x 5 ; GPIa ; HPa-5 ; système d’alloantigène plaquettaire humain 5 ; intégrine alpha 2 ; intégrine alpha-2 ; sous-unité d’intégrine alpha 2 ; intégrine, alpha 2 ; intégrine, alpha 2 (CD49B, sous-unité alpha 2 du récepteur VLA-2) ; ITGA2 ; Br de l’antigène plaquettaire ; GPIa de la glycoprotéine plaquettaire ; Ia de la glycoprotéine membranaire plaquettaire ; récepteur 2 de la protéine d’activation très tardive, sous-unité alpha-2 ; VLA-2 ; récepteur de VLA2 ; récepteur de VLA-2, sous-unité d’alpha 2 ; sous-unité de VLA-2 alpha ; VLAA2
Dose range
0.102 to 25 ng/ml
Sensitivity of the dosage
0.1 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human ITGA2 quantitates human ITGA2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ITGA2.
Human ITGA2 quantitates human ITGA2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ITGA2.
CD49b (integrin alpha 2, chain d的intrin alpha 2, chain VLA-2 alpha, HM alpha 2) is a member of the integrin family. It is a glycoprotein with a molecular weight of 150 kD and a combination with CD29 (integrin beta 1) to form the heterodimer complex VLA-2 (integrin alpha 2 beta 1 or GPIa/IIa). VLA-2 is an extracellular receptor for laminin, collagen and fibronectin, and interaction with its ligands results in activation of intracellular signaling pathways. He reported roles in VEGF-induced angiogenesis in vivo, as well as in lymphocytic adhesion and activation. CD49b is expressed as NK cells, NK-T cells, monocytes, platelets, and epithelial cells. It is also expressed on adaptive immune cells such as T and B cells, specifically on a subset of CD4+ T cells in the spleen, intraepithelial lymphocytes and lamina propria in the intestine, as well as on a population of T-regulating cells of type 1 CD4+ peripherals (Tr1) that coexpress LAG-3.
Sensitivity
Sensitivity of dosage: 0.1 ng/ml.
Measurement range
Dose range: 0.102 to 25 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: CD49b (integrin alpha 2).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17135049
Specifications
Accession number
alpha 2 subunit of the VLA-2 receiver; BDPLT9; BR; member of the family similar to CD49 B antigen; CD49B; collagen receptor; D x 5; GPIa; HPa-5; human platelet alloantigen system 5; alpha integrin 2; alpha-2 integrin; alpha 2 integrin subunit; alpha integrin